How are COO strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the COO strangle priced from the September 29, 2026 end-of-day chain at a 30-day expiry (ATM IV 28.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$532.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a COO strangle?

The breakeven for the COO strangle priced on this page is roughly $49.68 and $65.33 at expiration, derived from the September 29, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The COO market-implied 1-standard-deviation expected move in the same options snapshot is approximately 8.03%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current COO implied volatility affect this strangle?

COO ATM IV is at 28.00% with IV rank near 6.68%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

COO Strangle Strategy

COO (The Cooper Companies, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices.

COO (The Cooper Companies, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $10.80B, a trailing P/E of 18.78, a beta of 0.82 versus the broader market, a 52-week range of 51.01-89.83, average daily share volume of 3.1M, a public-listing history dating back to 1983, approximately 15K full-time employees. These structural characteristics shape how COO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.82 places COO roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on COO?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

COO snapshot

As of September 29, 2026, spot at $56.53, ATM IV 28.00%, IV rank 6.68%, expected move 8.03%. The strangle on COO below is built from the September 29, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 80-day expiry.

Why this strangle structure on COO specifically: COO IV at 28.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a COO strangle, with a market-implied 1-standard-deviation move of approximately 8.03% (roughly $4.54 on the underlying). The 80-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COO expiries trade a higher absolute premium for lower per-day decay. Position sizing on COO should anchor to the underlying notional of $56.53 per share and to the trader's directional view on COO stock.

COO strangle setup

The COO strangle below is built from the September 29, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COO at $56.53 on that close, the first option leg uses a $60.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COO chain at a 80-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COO shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$60.00	$2.63
Buy 1	Put	$55.00	$2.70

COO strangle risk and reward

Net Premium / Debit: -$532.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$532.50
Breakeven(s): $49.68, $65.33
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

COO strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on COO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$4,966.50
$12.51	-77.9%	+$3,716.70
$25.01	-55.8%	+$2,466.90
$37.50	-33.7%	+$1,217.10
$50.00	-11.5%	-$32.70
$62.50	+10.6%	-$282.51
$75.00	+32.7%	+$967.29
$87.50	+54.8%	+$2,217.09
$99.99	+76.9%	+$3,466.89
$112.49	+99.0%	+$4,716.69

When traders use strangle on COO

Strangles on COO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the COO chain.

COO thesis for this strangle

The market-implied 1-standard-deviation range for COO extends from approximately $51.99 on the downside to $61.07 on the upside. A COO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current COO IV rank near 6.68% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on COO at 28.00%. As a Healthcare name, COO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COO-specific events.

COO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COO alongside the broader basket even when COO-specific fundamentals are unchanged. Always rebuild the position from current COO chain quotes before placing a trade.

Frequently asked questions

What is a strangle on COO?: A strangle on COO is the strangle strategy applied to COO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With COO stock at $56.53 on the September 29, 2026 close, the strikes shown on this page are snapped to the nearest listed COO chain strike and the premiums come straight from that session's bid/ask midpoint.
How are COO strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the COO strangle priced from the September 29, 2026 end-of-day chain at a 30-day expiry (ATM IV 28.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$532.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a COO strangle?: The breakeven for the COO strangle priced on this page is roughly $49.68 and $65.33 at expiration, derived from the September 29, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The COO market-implied 1-standard-deviation expected move in the same options snapshot is approximately 8.03%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on COO?: Strangles on COO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the COO chain.
How does current COO implied volatility affect this strangle?: COO ATM IV is at 28.00% with IV rank near 6.68%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.